/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

S

Shinzaburo Noguchi

Hyogo Prefectural Nishinomiya Hospital(JP)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

498

Papers

22.2K

Citations

75

h-index

287

i10-index

Shinzaburo Noguchi is an academic researcher from Hyogo Prefectural Nishinomiya Hospital. The author has contributed to research in topics: Breast Cancer Treatment Studies & Estrogen and related hormone effects & Cancer Treatment and Pharmacology. The author has an h-index of 75, co-authored 424 publications.

Research Topics

Breast Cancer Treatment Studies Estrogen and related hormone effects Cancer Treatment and Pharmacology HER2/EGFR in Cancer Research Breast Lesions and Carcinomas

Papers by this author

works

Stem cell marker aldehyde dehydrogenase 1‐positive breast cancers are characterized by negative estrogen receptor, positive human epidermal growth factor receptor type 2, and high Ki67 expression

2009 · Cancer Science · 223 citations

https://doi.org/10.1111/j.1349-7006.2009.01151.x

Koji Morimoto Seung Jin Kim Tomonori Tanei Kenzo Shimazu

Incidence and time course of everolimus-related adverse events in postmenopausal women with hormone receptor-positive advanced breast cancer: insights from BOLERO-2

2014 · Annals of Oncology · 126 citations

https://doi.org/10.1093/annonc/mdu009

Hope S. Rugo Kathleen I. Pritchard Michael Gnant Shinzaburo Noguchi

Reduction of BRCA1 protein expression in Japanese sporadic breast carcinomas and its frequent loss in BRCA1-associated cases.

1999 · PubMed · 117 citations

Kiyotsugu Yoshikawa Kazuo Honda T Inamoto Hiromitsu Shinohara

Safety and Efficacy of Everolimus With Exemestane vs. Exemestane Alone in Elderly Patients With HER2-Negative, Hormone Receptor–Positive Breast Cancer in BOLERO-2

2013 · Clinical Breast Cancer · 110 citations

https://doi.org/10.1016/j.clbc.2013.08.011

Kathleen I. Pritchard Howard A. Burris Yoshinori Ito Hope S. Rugo

Abnormal expression of BRCA1 and BRCA1-interactive DNA-repair proteins in breast carcinomas

2000 · International Journal of Cancer · 89 citations

https://doi.org/10.1002/1097-0215(20001001)88:1<28::aid-ijc5>3.0.co;2-4

Kiyotsugu Yoshikawa Tomoko Ogawa Richard Baer Hiromichi Hemmi

Randomized phase III trial of trastuzumab monotherapy followed by trastuzumab plus docetaxel versus trastuzumab plus docetaxel as first-line therapy in patients with HER2-positive metastatic breast cancer: the JO17360 Trial Group

2009 · Breast Cancer Research and Treatment · 89 citations

https://doi.org/10.1007/s10549-009-0498-7

Kenichi Inoue Kazuhiko Nakagami Mitsuhiro Mizutani Yasuo Hozumi

Research topics

topics

Breast Cancer Treatment Studies

Estrogen and related hormone effects

Cancer Treatment and Pharmacology

HER2/EGFR in Cancer Research

Breast Lesions and Carcinomas

Chat about Author

Papers

Chat

Click to start Chat